Serina Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Prepaid Expense and Other Assets of $664.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $164.00K, a 59.80% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $500.00K.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $143.00K.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$766.00K.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$673.00K, a 135.31% decline from fiscal 2024.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.91M.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$16.00K.
- Serina Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$896.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $664.00K 10-Q · filed 2026-08-13 | $807.00K derived: sum of 3 quarters · filed 2026-08-13 | $41.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-14 | $643.00K derived: sum of 2 quarters · filed 2026-05-14 | -$123.00K derived: sum of 3 quarters · filed 2026-05-14 | $285.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$623.00K derived: sum of 2 quarters · filed 2026-03-25 | -$215.00K derived: sum of 3 quarters · filed 2026-08-13 | -$673.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$358.00K derived: sum of 2 quarters · filed 2026-08-13 | -$816.00K 10-Q · filed 2025-11-13 | -$1.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$50.00K 10-Q · filed 2026-08-13 | -$593.00K derived: sum of 3 quarters · filed 2026-08-13 | -$823.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$458.00K 10-Q · filed 2026-05-14 | -$1.00M derived: sum of 2 quarters · filed 2026-05-14 | -$1.23M derived: sum of 3 quarters · filed 2026-05-14 | $1.39M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$773.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.85M derived: sum of 3 quarters · filed 2026-03-25 | $1.91M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.39M derived: sum of 2 quarters · filed 2025-11-13 | $2.45M 10-Q · filed 2025-11-13 | $2.44M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.68M 10-Q · filed 2025-08-11 | $2.69M 10-Q · filed 2024-08-09 | $2.67M derived: sum of 3 quarters · filed 2025-08-11 | $2.66M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-08 | $43.00K derived: sum of 2 quarters · filed 2025-05-08 | $42.00K derived: sum of 3 quarters · filed 2025-05-08 | $42.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$15.00K derived: sum of 2 quarters · filed 2025-03-24 | -$15.00K derived: sum of 3 quarters · filed 2025-03-24 | -$16.00K 10-K · filed 2025-03-24 | -$1.09M 10-K · filed 2024-03-22 | |||
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.00K derived: sum of 2 quarters · filed 2024-11-12 | -$2.00K 10-Q · filed 2024-11-12 | -$1.13M 10-Q · filed 2023-11-14 | $8.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.00K 10-Q · filed 2024-08-09 | -$721.00K 10-Q · filed 2023-08-14 | $9.00K derived: sum of 3 quarters · filed 2024-08-09 | -$283.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$1.00K 10-Q · filed 2024-05-14 | -$314.00K 10-Q · filed 2023-05-12 | $9.00K derived: sum of 2 quarters · filed 2024-05-14 | -$283.00K derived: sum of 3 quarters · filed 2024-05-14 | -$654.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$282.00K derived: sum of 2 quarters · filed 2024-03-22 | -$653.00K derived: sum of 3 quarters · filed 2024-03-22 | -$896.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | -$292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$663.00K derived: sum of 2 quarters · filed 2023-11-14 | -$906.00K 10-Q · filed 2023-11-14 | -$984.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$614.00K 10-Q · filed 2023-08-14 | -$692.00K derived: sum of 3 quarters · filed 2023-08-14 | -$902.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$243.00K 10-Q · filed 2023-05-12 | -$321.00K derived: sum of 2 quarters · filed 2023-05-12 | -$531.00K derived: sum of 3 quarters · filed 2023-05-12 | -$886.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$288.00K derived: sum of 2 quarters · filed 2023-03-31 | -$643.00K derived: sum of 3 quarters · filed 2023-03-31 | -$760.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$565.00K derived: sum of 2 quarters · filed 2022-11-10 | -$682.00K 10-Q · filed 2022-11-10 | -$693.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$472.00K 10-Q · filed 2022-08-12 | -$483.00K derived: sum of 3 quarters · filed 2022-08-12 | -$721.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$117.00K 10-Q · filed 2022-05-13 | -$128.00K derived: sum of 2 quarters · filed 2022-05-13 | -$366.00K derived: sum of 3 quarters · filed 2022-05-13 | -$579.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$249.00K derived: sum of 2 quarters · filed 2022-03-29 | -$462.00K derived: sum of 3 quarters · filed 2022-03-29 | -$663.00K 10-K · filed 2022-03-29 | -$839.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$451.00K derived: sum of 2 quarters · filed 2021-11-12 | -$652.00K 10-Q · filed 2021-11-12 | -$767.00K 10-Q · filed 2020-11-16 | -$794.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$414.00K 10-Q · filed 2021-08-13 | -$511.00K 10-Q · filed 2020-08-14 | -$556.00K derived: sum of 3 quarters · filed 2021-08-13 | -$528.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$201.00K 10-Q · filed 2021-05-17 | -$195.00K 10-Q · filed 2020-05-14 | -$343.00K derived: sum of 2 quarters · filed 2021-05-17 | -$315.00K derived: sum of 3 quarters · filed 2021-05-17 | -$738.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$114.00K derived: sum of 2 quarters · filed 2021-03-31 | -$537.00K derived: sum of 3 quarters · filed 2021-03-31 | -$473.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$395.00K derived: sum of 2 quarters · filed 2020-11-16 | -$331.00K 10-Q · filed 2020-11-16 | -$212.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$359.00K 10-Q · filed 2020-08-14 | -$240.00K derived: sum of 3 quarters · filed 2020-08-14 | -$232.00K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $64.00K 10-Q · filed 2020-05-14 | $183.00K derived: sum of 2 quarters · filed 2020-05-14 | $191.00K derived: sum of 3 quarters · filed 2020-05-14 | $254.00K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $119.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $127.00K derived: sum of 2 quarters · filed 2020-03-31 | $190.00K derived: sum of 3 quarters · filed 2020-03-31 | $219.00K 10-K/A · filed 2020-03-31 | $293.00K 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $71.00K derived: sum of 2 quarters · filed 2019-11-14 | $100.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $92.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $29.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$10.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |